A meningitis B outbreak linked to a nightclub in Kent has triggered a rush for vaccines, leading to shortages at high street pharmacies. The outbreak, which began at Club Chemistry in Canterbury in early March, has resulted in two deaths and several serious infections among university students. Health authorities have launched a major response, offering antibiotics to 30,000 people and planning to vaccinate up to 5,000 University of Kent students.
Health Secretary Wes Streeting has urged calm, stating that the risk of transmission is low and advising against seeking private vaccinations. However, Boots and Superdrug have reported a significant spike in bookings, with some locations running out of stock. The outbreak has been described by experts as the largest cluster of meningitis cases in a generation, likely caused by a super-spreading event.
Professor Andrew Preston, an expert on the disease from the University of Bath, noted that the sudden onset and severity of symptoms, particularly among young people, have heightened public concern. Meningitis can cause rapid deterioration, with mild symptoms escalating to life-threatening conditions within hours. Despite the outbreak, Preston emphasised that meningitis remains rare in the UK, thanks to effective vaccination programmes.
The UK's immunisation schedule includes vaccines for several meningitis strains, with a programme for year 9 students targeting strains A, C, W, and Y achieving an 88% vaccination rate before the pandemic. These strains now account for less than 20% of cases. The current outbreak has reignited debates about the adequacy of the vaccination regime, particularly for meningitis B.
